Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.
Saved in:
| Title: | Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial. |
|---|---|
| Authors: | Han, Ting1 (AUTHOR), Zhuo, Meng1 (AUTHOR), Zheng, Xinyi2 (AUTHOR), Wu, Xiuqi1 (AUTHOR), Jiao, Feng1 (AUTHOR), Cui, Jiujie1 (AUTHOR), Wang, Tao3 (AUTHOR), Qiu, Xiaoxia1 (AUTHOR), Su, Yingjie4 (AUTHOR), Lin, Xiaolin1 (AUTHOR) renjilxl@163.com, Xiao, Xiuying1 (AUTHOR) xiaoxiuying2002@163.com |
| Source: | Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p2073-2084. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 190201794 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Han%2C+Ting%22">Han, Ting</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhuo%2C+Meng%22">Zhuo, Meng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Xinyi%22">Zheng, Xinyi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Xiuqi%22">Wu, Xiuqi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiao%2C+Feng%22">Jiao, Feng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cui%2C+Jiujie%22">Cui, Jiujie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Tao%22">Wang, Tao</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+Xiaoxia%22">Qiu, Xiaoxia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Su%2C+Yingjie%22">Su, Yingjie</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Xiaolin%22">Lin, Xiaolin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> renjilxl@163.com</i><br /><searchLink fieldCode="AR" term="%22Xiao%2C+Xiuying%22">Xiao, Xiuying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> xiaoxiuying2002@163.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cellular+Oncology+%282211-3428%29%22">Cellular Oncology (2211-3428)</searchLink>. Dec2025, Vol. 48 Issue 6, p2073-2084. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190201794 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13402-025-01127-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 2073 Titles: – TitleFull: Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Han, Ting – PersonEntity: Name: NameFull: Zhuo, Meng – PersonEntity: Name: NameFull: Zheng, Xinyi – PersonEntity: Name: NameFull: Wu, Xiuqi – PersonEntity: Name: NameFull: Jiao, Feng – PersonEntity: Name: NameFull: Cui, Jiujie – PersonEntity: Name: NameFull: Wang, Tao – PersonEntity: Name: NameFull: Qiu, Xiaoxia – PersonEntity: Name: NameFull: Su, Yingjie – PersonEntity: Name: NameFull: Lin, Xiaolin – PersonEntity: Name: NameFull: Xiao, Xiuying IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 22113428 Numbering: – Type: volume Value: 48 – Type: issue Value: 6 Titles: – TitleFull: Cellular Oncology (2211-3428) Type: main |
| ResultId | 1 |